Is Entrada Therapeutics, Inc. (TRDA) a Buy, Sell, or Hold?
NASDAQ : TRDA
Entrada Therapeutics, Inc. — Analyst Ratings
$7.67 USD
$0.63 (8.95%)
- Volume
- 260.81K
- Average Volume
- 406.57K
- Market Capitalization
- $297.75M
- P/E Ratio
- -1.93
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $16.45
- Year Low
- $5.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.89
Analyst Consensus Summary
Consensus Rating
Sell
6 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-45.2%
vs Current Price
Price Target
$14.00
Average TargetPrice Target Range
Lowest Target
$11.00
-30.3% DOWNSIDE
Average Target
$14.00
Median Estimate
Highest Target
$17.00
-54.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 6
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Oppenheimer | Kostas Biliouris | $21 | $11 | 2026-01-28 07:34 AM | 90.9% |
| H.C. Wainwright | Boobalan Pachaiyappan | $20 | $18.025 | 2024-11-06 06:41 AM | 11.0% |
| H.C. Wainwright | Raghuram Selvaraju | $18 | $14.24 | 2024-06-25 02:24 AM | 26.4% |